Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Exelixis Inc
(NQ:
EXEL
)
36.25
+0.45 (+1.26%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Exelixis Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
NASDAQ:EXEL is an undervalued gem with solid fundamentals.
Today 7:30 EST
For those who appreciate value investing, EXELIXIS INC (NASDAQ:EXEL) is a compelling option with its solid fundamentals.
Via
Chartmill
3 Magnificent Stocks Under $100 to Buy in November
November 03, 2024
The price could be right for these stocks.
Via
The Motley Fool
Reddit, Roblox And Garmin Are Among Top 10 Large Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
November 03, 2024
The top 10 performers last week were Reddit, Paycom, Mobileye, Exelixis, Garmin, Roblox, Twilio, Snap, Waters, and Atlassian. Many analysts raised price forecasts.
Via
Benzinga
Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday
October 30, 2024
Via
Benzinga
Earnings Preview: Exelixis
October 28, 2024
Via
Benzinga
1 No-Brainer Stock to Buy With $40
October 23, 2024
The midcap biotech just became an even better buy.
Via
The Motley Fool
Analyst Ratings For Exelixis
October 21, 2024
Via
Benzinga
Navigating 16 Analyst Ratings For Exelixis
October 21, 2024
Via
Benzinga
Exelixis (EXEL) Q3 2024 Earnings Call Transcript
October 30, 2024
EXEL earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Biotech Momentum Trades For The Q4 Rally
October 29, 2024
The biotech sector made an interim peak in late February followed by an active summer in very choppy trading.
Via
Talk Markets
Momentum Has Narrowed Again, Significantly
October 28, 2024
It is more of a stock pickers market than usual as momentum factors are currently exaggerated.
Via
Talk Markets
In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals.
October 18, 2024
In a market where value is scarce, EXELIXIS INC (NASDAQ:EXEL) offers a refreshing opportunity with its solid fundamentals.
Via
Chartmill
Blue Skies, New Highs Remain Disciplined And Do Not Chase Extended Ideas
October 13, 2024
It is Fall clean up time. Sell lagging and sagging companies.
Via
Talk Markets
Key Takeaways From Exelixis Analyst Ratings
October 04, 2024
Via
Benzinga
A Closer Look at 5 Analyst Recommendations For Exelixis
September 18, 2024
Via
Benzinga
NASDAQ:EXEL, an undervalued stock with good fundamentals.
August 15, 2024
Don't overlook EXELIXIS INC (NASDAQ:EXEL)—it's a hidden gem with strong fundamentals and an attractive price tag.
Via
Chartmill
Expert Outlook: Exelixis Through The Eyes Of 5 Analysts
August 08, 2024
Via
Benzinga
NASDAQ:EXEL appears to be flying under the radar despite its strong fundamentals.
September 27, 2024
For those who appreciate value investing, EXELIXIS INC (NASDAQ:EXEL) is a compelling option with its solid fundamentals.
Via
Chartmill
2 Growth Stocks to Buy With Less Than $100
September 26, 2024
No need to break the bank to get in on these likely long-term winners.
Via
The Motley Fool
In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals.
September 06, 2024
EXELIXIS INC (NASDAQ:EXEL): good value for what you're paying.
Via
Chartmill
Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review
August 09, 2024
After Monday's panicked global sell-off, markets have calmed down.
Via
Investor's Business Daily
Analyst Sees Exelixis At Inflection Point Despite Mixed Trial Results
August 07, 2024
Exelixis reports strong Q2 earnings with adjusted EPS of $0.84, surpassing estimates. The CONTACT-02 trial for mCRPC showed significant PFS benefit but OS did not achieve statistical significance....
Via
Benzinga
Exposures
Product Safety
US Stocks Set To Extend Gains Despite Mixed Earnings, VIX Dips Back Toward Pre-Sell-Off Levels: Analyst Says Pullback Is A 'Growth Scare' And Not 'Calamity'
August 07, 2024
Wall Street could go from strength to strength as the index futures point to another session in the green as investors seek to put the worst behind. Volatility continued to drop, as evidenced by...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Exelixis (EXEL) Q2 2024 Earnings Call Transcript
August 07, 2024
EXEL earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
EXEL Stock Earnings: Exelixis Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
EXEL stock results show that Exelixis beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Wall Street Rebounds After Selloff, VIX Falls, Dollar Surges Against Yen: What's Driving Markets Tuesday?
August 06, 2024
U.S. stock markets saw a strong recovery on Tuesday, with both the S&P 500 and the Nasdaq 100 climbing over 2%, nearly offsetting Monday’s losses. Investors took advantage of recent volatility to buy...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Economy
US Equities
In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals.
July 18, 2024
EXELIXIS INC (NASDAQ:EXEL): good value for what you're paying.
Via
Chartmill
7 Cheap Biotech Stocks With Major Upside Potential
July 09, 2024
While the broader healthcare sector enjoys permanent relevance, you can potentially maximize your upside with cheap biotech stocks.
Via
InvestorPlace
US Stocks Set To Open Higher After Monday's Crash, VIX Plummets: Analyst Says Would Have Worried If Market Surged Higher Without Correction
August 06, 2024
Strong sell-off may be viewed as an opportunity to load up beaten-down stocks but traders may seek evidence regarding sustainability of uptrend.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
When you look at NASDAQ:EXEL, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
June 27, 2024
When you look at EXELIXIS INC (NASDAQ:EXEL), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.